Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals | HCV Guidance

HCV Guidance: Recommendations for Testing, Managing, and Treating Hepatitis C

Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals

Trudeau S, Mendiratta V, Dababneh Y, Hollingsworth J, Gordon SC. Letter to the Editor: Successful treatment of multidrug resistant hepatitis C after >12 months of continuous therapy with direct-acting antivirals. Hepatology. 2022;.

Publication Type:

Journal Article

Authors:

Trudeau, Sheri; Mendiratta, Vivek; Dababneh, Yara; Hollingsworth, Jennifer; Gordon, Stuart C.

Source:

Hepatology (2022)

Notes:

Published online ahead of print, 2022 Jul 27

Cited On:

Multiple DAA Treatment Failures (All Genotypes), Including Sofosbuvir/Velpatasvir/Voxilaprevir or Sofosbuvir Plus Glecaprevir/Pibrentasvir

External Third-party Web Link:

https://doi.org/10.1002/hep.32688

Export Citation:

RIS Format

Top